Announcement on Voluntary Disclosure of the Approval Notice for Drug Clinical Trial of SI-B036 Bispecific Antibody Injection for Treatment of Locally Advanced or Metastatic Solid Tumors

About this update from Sichuan Biokin Pharmaceutical Co., Ltd. Class A

Announcement on Voluntary Disclosure of the Approval Notice for Drug Clinical Trial of SI-B036 Bispecific Antibody Injection for Treatment of Locally Advanced or Metastatic Solid Tumors The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sichuan Biokin Pharmaceutical Co., Ltd. Class A